Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
LIBERATOR MEDICAL HOLDINGS, INC. (LBMH)
|
Add to portfolio |
|
|
|
| Price: |
$3.35
| | Metrics |
| OS: |
53.9
|
M
| |
|
|
| Market cap: |
$181
|
M
| |
20
|
% ROIC
|
|
Net cash:
|
$7.93
|
M
| |
$0.15
|
per share
|
|
EV:
|
$173
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$23.5
|
M
| |
7.3
|
x EV/EBITDA
|
|
EBIT
|
$11.9
|
M
| |
14.4
|
x EV/EBIT
|
| EPS |
$0.10
| |
32.1
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Sep-30-15 | Sep-30-14 | Sep-30-13 | Sep-30-12 | Sep-30-11 | Sep-30-10 | Sep-30-09 | Sep-30-08 |
| Revenues | 81.6 | 74.6 | 69.1 | 0.1 | 52.7 | 40.9 | 25.8 | 9.6 |
| Revenue growth | 9.4% | 7.9% | 91951.0% | -99.9% | 28.8% | 58.5% | 170.3% | 324.4% |
| Cost of goods sold | 31.5 | 27.8 | 25.7 | 0.0 | 20.6 | 14.3 | 9.1 | 3.4 |
| Gross profit | 50.1 | 46.8 | 43.4 | 0.0 | 32.1 | 26.6 | 16.8 | 6.1 |
| Gross margin | 61.4% | 62.7% | 62.8% | 49.3% | 60.9% | 64.9% | 64.9% | 64.0% |
| Sales and marketing | 11.2 | 9.9 | 8.9 | | 8.2 | 4.6 | 2.0 | 0.5 |
| General and administrative | 6.0 | 5.4 | 4.7 | 0.0 | | | 3.2 | 2.5 |
| EBITA | 12.1 | 12.8 | 11.8 | 0.0 | 2.6 | 4.6 | 3.3 | -0.8 |
| EBITA margin | 14.8% | 17.2% | 17.1% | 5.7% | 5.0% | 11.3% | 12.7% | -8.4% |
| Amortization of intangibles | 0.1 | 0.1 | 0.1 | | 0.0 | | | |
| EBIT | 11.9 | 12.7 | 11.8 | 0.0 | 2.6 | 4.6 | 3.3 | -0.8 |
| EBIT margin | 14.6% | 17.0% | 17.0% | 5.7% | 4.9% | 11.3% | 12.7% | -8.4% |
| Pre-tax income | 11.9 | 12.7 | 11.7 | 0.0 | 1.7 | 2.7 | 2.3 | -1.3 |
| Income taxes | 4.6 | 4.9 | 4.6 | 0.0 | 1.4 | 0.1 | 0.0 | 0.0 |
| Tax rate | 38.5% | 38.4% | 39.4% | 40.9% | 84.4% | 3.6% | 1.4% | 0.0% |
| Net income | 7.3 | 7.8 | 7.1 | 0.0 | 0.3 | 2.6 | 2.2 | -1.3 |
| Net margin | 9.0% | 10.5% | 10.2% | 3.3% | 0.5% | 6.4% | 8.6% | -13.7% |
| |
| Diluted EPS | $0.14 | $0.15 | $0.14 | $0.05 | $0.00 | $0.05 | $0.05 | ($0.04) |
| Shares outstanding (diluted) | 53.7 | 53.7 | 52.4 | 0.1 | 53.6 | 52.6 | 43.6 | 31.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|